Our Chairman of the Board of Directors, Nathan Imperiale, was recently invited by Philip Leider, President of the Board of the Sarcoma Alliance, to present about the Synovial Sarcoma Foundation in a live webinar hosted by the Sarcoma Alliance. The conversation covered the Foundation’s origin…
Synovial Sarcoma of the Hyoid Bone: A Rare Case
A case report by Ryan Toledo, Jennifer Khong, and colleagues (published August 31, 2026; DOI: 10.7812/TPP/26.039) describes only the third known synovial sarcoma arising from the hyoid bone, a small U-shaped bone in the neck. The patient, a 62-year-old man, remains disease-free years after treatment.…
Two clinical trials testing TCR-NK cell therapy for advanced synovial sarcoma are now recruiting patients, one in the United States and one in the United Kingdom. Both use donor-derived natural killer cells engineered to target proteins commonly found on synovial sarcoma tumors. What Is TCR-NK…
Synovial Sarcoma of the Parotid Gland in Infancy: A Rare Case Study
Synovial sarcoma most often develops near the large joints of the arms or legs, but in rare cases it can…
Monophasic Synovial Sarcoma of the Posterior Pharyngeal Wall: A Rare Case Study
Content Warning:This article references a published medical case study that includes graphic surgical images involving the head and neck region.…
UI Health Care Begins Treating Patients With TCR Therapy for Synovial Sarcoma
UI Health Care has begun treating eligible patients with synovial sarcoma using a new form of immunotherapy known as T…
Prasterone (DHEA) for Metastatic or Unresectable Synovial Sarcoma
Researchers have studied prasterone—also known as DHEA (dehydroepiandrosterone)—as a potential treatment option for people with synovial sarcoma that has spread…
Celebrating Milestones with Hope: The 100th Sign-Up for the Synovial Sarcoma Registry and Biospecimen Repository
We are thrilled to announce a significant milestone for the Synovial Sarcoma Registry and Biospecimen Repository, as we proudly welcome…
A New Cell Therapy Approach Advances Toward Clinical Testing in Synovial Sarcoma
Zelluna, a Norway-based biotechnology company, has announced the submission of a Clinical Trial Application (CTA) in the United Kingdom for…
Synovial Sarcoma Foundation Welcomes Julie Kramer as Community Engagement & Partnerships Manager
Current Patient to Drive Relationships and Support for the Synovial Sarcoma Community [Philadelphia, PA] – 12/12/25 – The Synovial Sarcoma…
Arizona Pioneers New Immune Therapy for Synovial Sarcoma Treatment
In a groundbreaking advancement in cancer treatment, a patient with synovial sarcoma in Arizona has become the first in the…
Revolutionary Insights Unveiled in Latest Synovial Sarcoma Research
A landmark study just published in Nature Communications finally pinpointed the exact “cell of origin” for synovial sarcoma — a rare, primitive…
